To further explore whether the effects of NRG1 on BC cells are mediated by the AKT/mTOR pathway, we utilized the AKT inhibitor ARQ751 trihydrochloride to suppress AKT/mTOR signaling in cancer cells. Here, AKT1 is linked to breast cancer.